Back to Agenda
Session 9 Track 3: The Emerging Role of Medical Science Liaisons in Clinical Research
Session Chair(s)
J. Lynn Bass, PharmD, RPh
Senior Director, Medical Science Liaisons
BridgeBio, United States
Learning Objective : At the end of this session, participants should be able to:- Illustrate appropriate role of the MSL in clinical development/operations
- Discuss metrics for evaluating the MSL’s role in clinical studies
- Evaluate future opportunities for collaboration between MSL teams and clinical development/operation
Speaker(s)
Speaker
Susan Shaffer, PharmD, MBA
AstraZeneca, United Kingdom
Head of Global Medical Capabilities, Respiratory
Speaker
James Walter, PhD
Merck Research Labs, United States
National Team Leader, Cardiometabolic RSDs, US Medical Affairs
Have an account?